Dendreon (DNDN) volatility flat into CMS reimbursement memo

March 28, 2011 12:13 PM EDT
Dendreon (Nasdaq: DNDN) is recently up $1.22 to $34.17 into the expected release of a CMS reimbursement memo on March 30. April put option implied volatility is at 43, August is at 47; below its 26-week average of 49 according to Track Data, suggesting decreasing price movement.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

FDA, Options

Related Entities

Options